Bionity.COM Newsletter No. 03/2010, 01/27/2010

New Products and Services

> more

Unique Raman-AFM Microscope Combination for Automated 3-D Chemical Imaging and Surface Inspection
WITec introduces the alpha500 and alpha700 series for automated Confocal Raman Imaging and Atomic Force Microscopy
The new alpha500 and alpha700 series allows for the automated chemical and structural characterization of large samples for the most comprehensive and rapid surface inspection on the sub-micron scale...

http://www.bionity.com/products/e/76485/

Request information

analytica 2010 - Hall A2, Stand 406

QIAgility - Pure Precision
Fully automated sample and assay technologies
The QIAgility enables rapid and efficient reaction setup in a wide range of formats and eliminates the tedious manual steps that can be prone to human error. Plus, you have more time for other important tasks...

http://www.bionity.com/products/e/111099/

Request information

SigmaPlot 11- Exact Graphs and Data Analysis
SigmaPlot - the fastest way to analyse and graph data
SigmaPlot is an easy-to-use technical graphing and data analysis software for scientists and engineers who produce defensible research and need to create exact, publication-quality graphs for technical publications, presentations or the web. The program is specifically tailored to scientific needs...

http://www.bionity.com/products/e/54805/

Request information

A world of flexibility : BIOS ANALYTIQUE Rental Solutions
European Partner of Agilent Technologies
Get the instrument you need without waiting for an investment budget! From 1 to 60 months, from one module to a complete system, whether to react on punctual needs or to strategically finance your equipment, you will find the right rental solution with us...

http://www.bionity.com/products/e/86425/

Request information

Licensed Endotoxin detection for the future
Endosafe-PTS is a rapid, point-of-use test system providing quantitative LAL results in about 15 minutes
The Endosafe-PTS utilizes LAL reagents in a disposable test cartridge with a handheld reader for a completely contained, real-time endotoxin testing system. This system is licensed by the FDA as testing method for in-process and final release testing of pharmaceutical products...

http://www.bionity.com/products/e/58128/

Request information

Xevo^TM QTof MS - For clear answers to your most complex questions
Scientific goals bring scientific challenges: such as accurately and routinely characterizing complex samples in a short amount of time, or getting faster access to quality information. Waters has the no-compromise answer: Xevo^TM QTof MS...

http://www.bionity.com/products/e/97810/

Request information

Biotech News

> more

Latest News from Biotechnology and Pharma from 01/20/2010 to 01/26/2010

Researchers trace effects of genetic defect in myotonic muscular dystrophy
01/26/2010 - Research on the genetic defect that causes myotonic muscular dystrophy has revealed that the mutation disrupts an array of metabolic pathways in muscle cells through its effects on two key proteins. A...
http://www.bionity.com/news/e/112268/

Merger of Biovitrum and Swedish Orphan
01/26/2010 - Biovitrum and Swedish Orphan have combined forming Swedish Orphan Biovitrum. The mission of the new company is to develop and make available orphan drugs and niche specialty pharmaceuticals for patien...
http://www.bionity.com/news/e/112284/

Arzerra (Ofatumumab) Receives Positive Opinion for Conditional Approval in Europe for Refractory Chronic Lymphocytic Leukaemia
01/26/2010 - GlaxoSmithKline and Genmab A/S announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Arzerra(TM) (ofatumumab), for th...
http://www.bionity.com/news/e/112257/

Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Trial of Long-Acting Hemophilia B Therapy
01/26/2010 - Biogen Idec and Swedish Orphan Biovitrum y announced that the first patient was dosed in a registrational, open-label, multicenter trial designed to evaluate the safety, pharmacokinetics and efficacy...
http://www.bionity.com/news/e/112285/

Genes found linked to breast cancer drug resistance could guide future treatment choices
01/26/2010 - Researchers at Dana-Farber Cancer Institute have discovered a gene activity signature that predicts a high risk of cancer recurrence in certain breast tumors that have been treated with commonly used ...
http://www.bionity.com/news/e/112269/

Minimal changes alter an enzyme dramatically
01/25/2010 - A new study by a research team at Uppsala University shows how new functions can develop in an enzyme. This can explain, for example, how resistance to toxins can occur so simply. The findings are now...
http://www.bionity.com/news/e/112192/

ConjuChem to evaluate strategic alternatives
01/25/2010 - ConjuChem Biotechnologies, Inc. announced that it has established a Special Committee of independent Board members to explore and evaluate all strategic alternatives including, but not limited to, a ...
http://www.bionity.com/news/e/112202/

Genera Biosystems receives TGA approval for its PapType HPV detection and genotyping test
01/25/2010 - Genera Biosystems announced that the Australian Therapeutic Goods Administration (TGA) has approved the entry of the company’s PapType Human Papillomavirus (HPV) test kit onto the Australian Register ...
http://www.bionity.com/news/e/112243/

Bioamber Commissions World's First Renewable Succinic Acid Plant
01/25/2010 - Bioamber, a joint venture between US-based DNP Green Technology andFrance-based ARD (Agro-industrie Recherches et Développements), announces the successful start-up and commissioning of the world's fi...
http://www.bionity.com/news/e/112207/

Membrane-coat proteins: Bacteria have them too
MBL discovery could yield evolutionary insights and new model organism
01/25/2010 - Although they are present almost everywhere, on land and sea, a group of related bacteria in the superphylum Planctomycetes-Verrucomicrobia-Chlamydiae, or PVC, have remained in relative obscurity ever...
http://www.bionity.com/news/e/112193/

Iowa State University researcher discovers Ebola's deadly secret
01/22/2010 - Research at Iowa State University has led scientists to uncover how the deadly Zaire Ebola virus decoys cells and eventually kills them. A research team led by Gaya Amarasinghe, an assistant professo...
http://www.bionity.com/news/e/112189/

Three new Novartis medicines approved in Japan for patients with type 2 diabetes, high blood pressure and advanced kidney cancer
Equa, Exforge and Afinitor provide new treatment options for unmet medical needs
01/22/2010 - Patients in Japan will benefit from the approval of three new Novartis medicines - Equa® (vildagliptin), marketed as Galvus® in the European Union, for the treatment of type 2 diabetes, Exforge® (vals...
http://www.bionity.com/news/e/112187/

Merck Builds New Production Plant for Pharmaceutical Raw Materials
New plant for the production of inorganic salts by crystallization
01/22/2010 - Merck KGaA announced that it has started construction work at its Darmstadt site on a production plant for the manufacture of inorganic salts. This will increase capacity by around 50% compared to the...
http://www.bionity.com/news/e/112179/

Cellectis and the French National Institute for Agricultural Research (INRA) sign cooperation agreement
01/22/2010 - André Choulika, CEO of Cellectis S.A. and Marion Guillou, President of the French National Institute for Agricultural Research (INRA), have signed a five year cooperation agreement. Cellectis and ...
http://www.bionity.com/news/e/112181/

Maik W. Jornitz elected Chair of the Board of the global Parenteral Drug Association
01/22/2010 - Maik W. Jornitz, Group Vice President of Global Marketing & Product Management for Filtration | Fermentation Technologies at Sartorius Stedim Biotech, is now Chair of the Board of the Parenteral Drug ...
http://www.bionity.com/news/e/112183/

Appendicitis may be related to viral infections
01/21/2010 - Can you catch appendicitis? And if you do, is it necessarily an emergency that demands immediate surgery? Yes and no, according to a new study by UT Southwestern Medical Center surgeons and physician...
http://www.bionity.com/news/e/112079/

InterMed Discovery Receives Michael J. Fox Foundation Award for IMD-026259
01/21/2010 - InterMed Discovery (IMD) announced that it has received an award from The Michael J. Fox Foundation for Parkinson’s Research for its programme to develop IMD-026259 as a pharmaceutical treatment to ch...
http://www.bionity.com/news/e/112180/

Largest academic-industry collaboration for drug discovery in depression and schizophrenia launched
01/21/2010 - An international consortium of scientists, led by H. Lundbeck A/S and King's College London, has launched one of the largest ever research academic-industry collaboration projects to find new methods ...
http://www.bionity.com/news/e/112080/

SQI Diagnostics Adds Autoimmune Disease Expert to Lead its Scientific Advisory Board
01/21/2010 - SQI Diagnostics Inc. announced that Professor Yehuda Shoenfeld, MD., has joined SQI's Scientific Advisory Board as Chairman to support the development of the Company's IgXPLEX(TM) assay and platform d...
http://www.bionity.com/news/e/112078/

Circassia Extends its Clinical-Stage Portfolio With Phase II Trials of T-Cell Vaccines Against House Dust Mite and Cat Allergies
01/21/2010 - Circassia Ltd announced that it has initiated phase II clinical trials of its T-cell vaccines targeting house dust mite and cat allergies. With the start of these studies, and the ongoing trial of Cir...
http://www.bionity.com/news/e/112077/

'Jekyll and Hyde' cell may hold key to muscular dystrophy, fibrosis treatment: UBC research
01/20/2010 - A team of University of British Columbia researchers has identified fat-producing cells that possess "dual-personalities" and may further the development of treatments for muscle diseases such as musc...
http://www.bionity.com/news/e/112026/

Biotie reports positive top-line data from clinical study with VAP-1 antibody in rheumatoid arthritis patients
01/20/2010 - Biotie reported that it has successfully completed a clinical trial with its fully human VAP-1 monoclonal antibody (BTT-1023) in rheumatoid arthritis patients.
The study evaluated the safety, toler...
http://www.bionity.com/news/e/112058/

Algeta and IFE agree to collaborate for the manufacture and supply of Alpharadin for future commercial use and clinical trials
01/20/2010 - Algeta ASA and the Institute for Energy Technology (IFE) have agreed to collaborate for the manufacture and supply of Alpharadin for future commercial use and clinical trials. No financial terms are ...
http://www.bionity.com/news/e/112001/

Molecular genealogy in the Arctic sediment
01/20/2010 - Heat-loving bacteria found in the Arctic seabed have their origins in oil springs and the depths of the Earth's crust. This is the finding of a project supported by the Austrian Science Fund FWF, whic...
http://www.bionity.com/news/e/112000/

PCI Biotech reports successful completion of second dose group in a Phase I/II Amphinex trial
Strong anti-tumour response observed in all patients
01/20/2010 - PCI Biotech reported that it has completed the treatment of the second dose group in the phase I/II study of its proprietary photosensitiser Amphinex® used in combination with the cytotoxic agent bleo...
http://www.bionity.com/news/e/112059/

Events

> more

Events, Workshops and Training Courses